Journal of Allergy and Clinical Immunology-In Practice

Article	Citations
Table of Contents	180
Sticking With It: The Continued Benefits of 2 Years of Peanut Epicutaneous Immunotherapy in Young Children	144
Indoor and Outdoor Fungal Allergens and Impacts on Respiratory Allergic Disease	134
Carboplatin risk stratification after a hypersensitivity reaction: Progress in our understanding of skin testing	117
Reply to “Correlation, causation, and confounding: How worried should we be about dementia risk and second-generation antihistamines?”	110
Managing CPAP Rhinitis	102
Adherence Challenges and Strategies in Specific Groups With Asthma: Adolescents, Pregnancy, and Older Adults	94
Could Corticosteroid/Antihistamine Combination Nasal Sprays Be Used as Anti-Inflammatory Reliever Therapy for Allergic Rhinitis?	91
Table of Contents	89
Respiratory Diseases Associated With Organic Dust Exposure	86
Once- or Twice-Daily Inhaler Therapy for Optimal Adherence: “No-Brainer” or Shared Decision?	84
Endoscopic Evaluation of Patients With Food Allergy for Eosinophilic Esophagitis Before Oral Immunotherapy	82
Weight Loss Interventions for Adults With Obesity-Related Asthma	78
Comparative diagnostic performance of mx4-IgE versus species-specific IgE for identifying allergic bronchopulmonary aspergillosis	78
Effects of Sex and Gender in Immediate β-Lactam Antibiotic Allergy: A Systematic Review and Meta-Analysis	77
Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders	74
The Role of Patient Satisfaction Scores in Clinical Care and Physician Wellness	74
Cumulative Dose Effects of H1 Antihistamine Use on the Risk of Dementia in Patients With Allergic Rhinitis	72
Understanding Health Equity in Patient-Reported Outcomes	71
Risk Factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-Analysis	70
Evolving Food Allergy Clinical Trials to Become More Patient-Centered	68
Combination of Allergen-Specific Immunotherapy With Biologics in Severe Asthma: Counterintuitive or Rational?	67
Artificial Intelligence and Machine Learning for Inborn Errors of Immunity: Current State and Future Promise	67
Chronic norovirus infection in immunodeficiency: A UK national case series	64
A Media Advocacy Toolkit for the Allergist-Immunologist	63

Reply to “Correspondence on ‘Neuropsychiatric events related to montelukast and pranlukast in adults with asthma and rhinitis: a 10-year nationwide population-based study’”	62
Measuring Cough Severity: Time to Replace VAS With Patient Global Impression Scale?	61
Facilitated Subcutaneous Immunoglobulin 10% Safety Among Pediatric Patients With Primary Immunodeficiency Diseases	61
Impact of Ongoing Treatment With Inhaled Corticosteroids During Specific Inhalation Challenges for Diagnosing Occupational Asthma	61
Allergic Rash Mimickers	59
Table of Contents	58
Smoking in severe asthma: Unraveling the overlap with COPD	56
Effects of Pregnancy-Onset Asthma on Perinatal Outcomes: A Retrospective Cohort Study	56
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis	55
Disparities in Genetic Testing for Inborn Errors of Immunity	55
Prevention of IgE-Mediated Food Allergy: Emerging Strategies Through Maternal and Neonatal Interventions	55
Epinephrine Nasal Spray Improves Allergic Symptoms in Patients Undergoing Oral Food Challenge, Phase 3 Trial	54
Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease	54
CME exam: Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity	53
The impact of COVID-19 on a national sample of US adults with food allergy	52
Practice Notes from the AAAI	52
Usability of Graphical User Interfaces With Semiautomatic Delabeling Feature to Improve Drug Allergy Documentation	51
Two-step nonsteroidal anti-inflammatory drug challenges during pregnancy: A case series	51
Another Therapy for Chronic Rhinosinusitis With Nasal Polyps	50
Pharmaceutical industry-sponsored meals and prescriptions of biologics for asthma	50
Artificial Intelligence Chatbots in Allergy and Immunology Practice: Where Have We Been and Where Are We Going?	49
Feeding difficulties in children with food protein–induced enterocolitis syndrome	49
Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines	48
Macular Amyloidosis in an Atopic Patient After Aeroallergen Immunotherapy	46
Keeping Our Eyes on the Prize: Personalized and Precision Medicine With Biologics for Chronic Rhinosinusitis With Nasal Polyps	46
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases	46
Resolution of hypereosinophilic syndrome following resection of a schwannoma	46
Ask Not What AI Can Do to Us, but What We Can Do with AI	45
Trends of Peanut-Induced Anaphylaxis Rates Before and After the 2017 Early Peanut Introduction Guidelines in Montreal, Canada	45
Original Article Highlights From This Issue	45
Information for Readers	45
CME exam: Take a Leap of Faith: Implement Routine Genetic Testing in Your Office	44
Generational Consequences From Historical Redlining: Longitudinal Impacts on Air Pollution and Asthma Health Outcomes	44
CME Exam: Long-Term Respiratory Consequences of Early-Life Respiratory Viral Infections: A Pragmatic Approach to Fundamental Questions	44
Scratching the Itch: Managing Recurrent Pruritic Skin Conditions	44
Managing Atopic Dermatitis in Patients With Skin of Color	44
Application of passive monitoring of nighttime respiratory symptoms in chronic asthma management	43
COVID-19 Treatments: Then and Now	43
Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80	43
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use	43
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives	42
Persistent nivolumab-induced urticaria with vibratory and delayed-pressure angioedema	42
Information for Readers	41
Identification of motivators and barriers impacting successful food introduction or reintroduction after negative oral food challenges	41
March 2023 Practice Notes	40
Giant Papillary Conjunctivitis Caused by a Fibroepithelial Polyp of the Lower Eyelid	40
Reducing Health Disparities in Asthma: How Can Progress Be Made	39
Gene Therapy for Inborn Errors of Immunity	39
Assessment of Real-World Escalation to Biologics in US Patients With Asthma	39
Assessing Pediatric Cephalosporin Allergic Reactions Through Direct Graded Oral Challenges	39

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases	38
Respiratory Infections in Patients with Primary Immunodeficiency	38
Is Once Versus Twice Daily Dosing Better for Adherence in Asthma and Chronic Obstructive Pulmonary Disease?	38
Triggers for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy	38
Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis	38
Development of Food Allergy Data Dictionary: Toward a Food Allergy Data Commons	37
Asthma Management in Children	37
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?	37
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America	37
Lung Effects of Household Air Pollution	37
Hormonal Contraceptives Are Associated With an Increase in Incidence of Asthma in Women	36
Quality and Safety: Learning from the Past and (Re)Imagining the Future	36
Skin Antiseptics for Atopic Dermatitis: Dissecting Facts From Fiction	35
Systemic Therapies for Atopic Dermatitis	35
Walnut Threshold Dose Distribution and Safe Dose in Allergic Patients (Nut CRACKER Study)	35
Anti-IL-5 Treatment Reduces Infection-Related Adverse Events: A Meta-Analysis of Phase 3 Clinical Trials	35
Table of Contents	35
Barriers and Enablers of Dietary Reintroduction Following Negative Oral Food Challenge: A Scoping Review	35
Organizing pneumonia in patients on dupilumab therapy for nasal polyposis: A report of three cases	34
Hypertension risk in patients having hereditary angioedema with plasminogen gene mutation K330E	34
Severity Trend of Recurrence in Pediatric Food Protein-Induced Enterocolitis Syndrome	34
Gender and geographically based disparities among editors and editorial board members in highly cited allergy journals	34
Factors Associated With Asthma Biologic Prescribing and Primary Adherence Among Adults in a Large Health System	34
Allergic Lymphangitis after Hymenoptera Sting	33
Does atopic dermatitis confer a clinically meaningful risk of cardiovascular disease?	33
Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National Cohort	33
Blue Wheals and Blue Angioedema Induced by Blue Dyes: A Systematic Review	33
Social Determinants and Quality of Life in Food Allergy Management and Treatment	33
Comorbid Scenarios in Contact Dermatitis: Atopic Dermatitis, Irritant Dermatitis, and Extremes of Age	33
Editorial Board	33
Effectiveness of Carboplatin-Prescreening Intradermal Skin Tests to Reduce Unanticipated Immediate Hypersensitivity Reactions: A Comparative Study	32
Sensitization is persistent in most patients with anaphylaxis to a cephalosporin at 10 years	32
Does Adherence to Inhaled Corticosteroids/Long-Acting β2-Agonists Matter in Patients With Severe Asthma Receiving Biologic Therapies?	32
Preimplantation genetic testing for hereditary angioedema as a potential dominant cost-effective intervention	32
Clinical and diagnostic features of 33 patients with aquagenic urticaria	32
Hazelnut Oral Immunotherapy Desensitizes Hazelnut But Not Other Tree Nut Allergies (Nut CRACKER Study)	32
Patient Global Impression of Severity Scale in Chronic Cough: Validation and Formulation of Symptom Severity Categories	32
Clinical and Molecular Characteristics of X-Linked Agammaglobulinemia Patients 55 Years or Older	31
Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts	31
Food Insecurity in the Food Allergic Population: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee	31
Burden of Allergic Disease in Racial and Ethnic Structurally Oppressed Communities Within Canada and the United States: A Scoping Review	31
The Prevalence of IgE-Mediated Food Allergy and Other Allergic Diseases in the First 10 Years: The Population-Based, Longitudinal HealthNuts Study	31
Take a Leap of Faith: Implement Routine Genetic Testing in Your Office	31
Telehealth and Allergy Services in Rural and Regional Locations That Lack Specialty Services	31
Use of Antibiotics in Infancy and Asthma in Childhood: Confounded or Causal Relationship? A Critical Review of the Literature	31
AIR Therapy: Improving Patient and Planetary Health	31
The Environmental Microbiome, Allergic Disease, and Asthma	31
Teleallergy: Where Have We Been and Where Are We Going?	30
The Challenges of Managing Multiple Food Allergies and Consequent Food Aversions	30
Clinical Characteristics of Irritant-Induced Occupational Asthma	30
Patient Perceptions of Penicillin Allergy Testing in a Public Health System	30
Clinical Assessment of Chronic Rhinosinusitis	30
Risk Factors and Age-Related Patterns of Asthma-Like Symptoms in Early Childhood	30
The added value of reporting likelihood ratios to laboratory test results in allergy and clinical immunology	30
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma	30
Frequent Allergic Sensitization to Farmed Edible Insects in Exposed Employees	29
Correction	29
Improving Detection of Alpha-1 Antitrypsin Deficiency: Role of the Allergist	29
Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey	29
Accelerating Food Allergy Research: Need for a Data Commons	29
Table of Contents	29
The Th17/IL-17 Axis and Host Defense Against Fungal Infections	28
Erratum	28
The Use of Flexible Rhinolaryngoscopy for Allergy-Immunology Practice	28
Acculturation and asthma in Asian American adults	28
Preparing the Allergist/Immunologist for the Next Pandemic	27
Hypersensitivity to galcanezumab with tolerance to erenumab and fremanezumab	27
Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation	27
September 2023 Practice Notes	27
Multiple chemical sensitivity/idiopathic environmental intolerance: A disability-rights, patient-led perspective	27
Domiciliary assessment of the type 2 inflammatory FeNO type	27
Screening Newborns for Low T Cell Receptor Excision Circles (TRECs) Fails to Detect Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome	27
Cost Control Versus Optimal Patient Care in Hereditary Angioedema	27
Outcomes among racial and ethnic minority groups with X-linked agammaglobulinemia from the USIDNET registry	27
Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency	27
December 2023 Practice Notes	26
Continuing Medical Education Calendar	26
Telemedicine utilization and incorporation of asynchronous testing in a pediatric allergy clinic during the COVID-19 pandemic	26
Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19	26
Asian American Patients With Allergic Diseases: Considerations for Research and Clinical Care	26

Infrared-induced hives	26
Omalizumab treatment reduces asthma exacerbations regardless of airway bronchodilator reversibility	26
Correction	26
CME exam: The Microbiome as a Gateway to Prevention of Allergic Disease Development	26
Continuing Medical Education Calendar	26
Safety of direct oral challenge to amoxicillin in pregnant patients at a Canadian tertiary hospital	26
Remission of indolent systemic mastocytosis in the absence of targeted therapy	26
Immediate adverse reactions to horse antithymocyte globulin: A 10-year single-center experience	26
A Community-Based Participatory Research Approach to Understanding Childhood Asthma in the Navajo Nation	25
Systemic Inflammation in Asthma: What Are the Risks and Impacts Outside the Airway?	25
Novel Connections of Common Childhood Illnesses Based on More Than 5 Million Diary Registrations From Birth Until Age 3 Years	25
About the Cover: A New “Image” for In Practice	25
Sesame-allergic patients can tolerate intact sesame seeds food challenge	25
Upadacitinib-induced remission of allergic asthma: A case report	25
Outpatient epinephrine administration reduces ICU admission rates in anaphylactic reactions: A propensity score–matched cohort	25
Clinical Remission in Patients With Biologic-Naïve Asthma: A Multicenter Study in Japan	25
The Heterogeneity of Stock Epinephrine Legislation in the United States	25
Altered Symptom Perception in Children With Asthma Is Associated With Poor Childhood Opportunity and Adverse Outcomes	25
Real-world utilization of Arachis hypogaea for peanut allergy: Patient and provider perspective	25
Environmental Injustice Is Associated With Poorer Asthma Outcomes in School-Age Children With Asthma in Metropolitan Atlanta, Georgia	24
Oral immunotherapy in US allergy practice	24
Beyond Avoidance: Advanced Therapies for Contact Dermatitis	24
Polycystic ovary syndrome and the risk of asthma in reproductive-age women: Insights from 2 real-world large cohorts	24
Relationships Between Chronic Cough and Asthma Control and Quality of Life in Patients With Severe Asthma: A 6-Month Longitudinal Analysis	24
Idiopathic Anaphylaxis Grand Rounds	24
Folliculocentric Mycosis Fungoides Masquerading as Angioedema and Allergic Contact Dermatitis	24
Asthma Lowers the Risk of COVID Hospitalization in Children: Impact of Symptom Control Status	24
Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria	24
Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy	24
Reply to “The use of basophil activation tests (BATs) in the diagnosis of penicillin allergy”	24
Delayed Skin Testing for Systemic Medications: Helpful or Not?	24
Genetic Counseling in Pediatric Inborn Errors of Immunity: Perspective Piece on Current Practice and Considerations	24
Analyzing Racial Disparities in Pediatric Atopic Comorbidity Emergency Department Visitation Using Electronic Health Records	24
Cover 1	24
Early-Life Allergen Exposure and Its Influence on Risk of Atopic Disease	24
Cautious interpretation of dupilumab’s superiority in asthma: Methodological limitations and subgroup-specific efficacy	24
Patient-Centered Immunotherapy: Empowering Patients With Dosing Schedule Education and Self-Tracking Modality	24
Milk or egg allergy diagnosis increases the risk of eosinophilic esophagitis diagnosis	24
Fatigue in Severe Uncontrolled Asthma	23
Diagnosis and Treatment Options for T2-Low Asthma	23
Information for Readers	23
Information for Readers	23
Original Article Highlights From This Issue	23
More Than Moderate-Dose Inhaled Corticosteroid Therapy for Difficult-to-Treat Asthma: One Step Too Many?	23
Current Management of Allergic Rhinitis	23
Budesonide/Formoterol or Budesonide/Albuterol as Anti-Inflammatory Reliever Therapy for Asthma	23
Why Was There Ever a Warning Not to Use Cephalosporins in the Setting of a Penicillin “Allergy”?	22
Risk of Self-Harm and the Use of Leukotriene Receptor Antagonists and Inhaled Corticosteroids: A Population-Based Study	22
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions	22
Inborn Errors of Immunity: A Role for Functional Testing and Flow Cytometry in Aiding Clinical Diagnosis	22
Asthma and Three Colinear Comorbidities: Obesity, OSA, and GERD	22
Real-World Effectiveness of Biologic Therapy in Allergic Bronchopulmonary Aspergillosis	22
Subcutaneous Emphysema Presenting as Bilateral Periorbital Angioedema	22
Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19	22
Drug Reaction With Eosinophilia and Systemic Symptoms: A Systematic Review	22
Allergic bronchopulmonary aspergillosis in identical twins: Effectiveness of dupilumab	22
COVID-19 and Pregnancy: Interrelationships With Asthma and Allergy	22
Demographic and clinical variations in pediatric eosinophilic esophagitis: Insights from a multidisciplinary clinic	22
A single-center experience of treating 19 patients with chronic cold urticaria	22
Eosinophilic Esophagitis Patients Are Not at Increased Risk of Severe COVID-19: A Report From a Global Registry	22
The Magnification of Health Disparities During the COVID-19 Pandemic	22
Association between social needs and asthma control among children evaluated at a single-center high-risk asthma clinic	21
Biologics and Personalized Medicine in Severe Asthma: One Step at a Time	21
Allergic Mucin in Allergic Fungal Rhinosinusitis	21
Pulmonary Infiltrates With Hypereosinophilia	21
Challenges and Opportunities in Asthma Prevention and Treatment	21
The Art of Dosing for Subcutaneous Immunotherapy in North America	21
Housing Mobility Intervention and the Impact on Pediatric Asthma Morbidity: A Novel Asthma-Directed Therapy	21
The Art of Immunotherapy	21
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical presentation and outcomes in people of color	21
Recent Advances in the Treatment of Eosinophilic Esophagitis	21
Exfoliative Dermatitis During Antituberculosis Treatment	21
Corrections	21
Elimination Diet or Swallowed Topical Steroid Treatment of Pediatric Eosinophilic Esophagitis: Five-Year Outcomes	21
Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights	21
Comparison of Standard, Cluster, and Rush Allergy Immunotherapy Buildup Protocols	21
Perceived high risk of COVID-19 vaccination: The revealing power of placebo	20
Smoke and the Lungs	20
CME exam: Methods for Cross-Cultural Communication in Clinic Encounters	20
Positive Basophil Tests Are Linked to High Disease Activity and Other Features of Autoimmune Chronic Spontaneous Urticaria: A Systematic Review	20
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus	20
Original Article Highlights From This Issue	20
Contact Dermatitis of a Surgical Wound	20
Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease	20
Trust but Verify	20
Should We Pretreat Before We Go Nuts? Antihistamines Modestly Reduce the Side Effects of Peanut Oral Immunotherapy	20
Exercising with Asthma: A Slow Burn or a Quick HIIT?	20
Novel Questionnaires for Assessing Signs and Symptoms of Eosinophilic Esophagitis in Children	20
Pretreatment with ibrutinib facilitates rapid drug desensitization in a difficult case of brentuximab vedotin–induced anaphylaxis	20
Association Between Blood Eosinophils and Neutrophils With Clinical Features in Adult-Onset Asthma	20
Racial and Ethnic Disparities in the Research and Care of Hereditary Angioedema Patients in the United States	20
Long-Term Adherence and Risk of Allergic Reactions in Patients Who Attained Milk Oral Immunotherapy Maintenance	19
An International Delphi Consensus on the Management of Pollen-Food Allergy Syndrome: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee	19
Household cleaning product exposure and severe bronchiolitis in infancy: A case-control study	19
Janus kinase inhibitors in pediatric patients with corticosteroid-resistant drug reaction with eosinophilia and systemic symptoms	19